glp-1 weight loss near me Semaglutide Clinic in Roseville, CA Semaglutide GLP-1 for Medical Weight
Description
One in 8 American adults now takes a GLP-1 drug to manage diabetes or obesity
In June 2024, the FDA officially approved tirzepatide for the treatment of obesity-associated OSAS, marking the first GLP-1based therapy worldwide to receive this indication (16)
doi: 10.1002/path.5056
The data is encouragingbut the timing is tricky
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis
These appear to be less important, however, as restoring GLP-1R in the pancreas in a receptor KO mouse restored glucose tolerance (61)
